ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000253327.2	ABT-263 (navitoclax)	Breast invasive carcinoma	0.028331243	Sensitive
ENSG00000253327.2	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.039566804	Sensitive